Marimastat 154039-60-8
Marimastat was a proposed antineoplastic drug developed by British Biotech. It acted as a broad-spectrum matrix metalloproteinase inhibitor. Marimastat performed poorly in clinical trials, and development was terminated.
read more [+]| Systematic (IUPAC) name: | N-[2,2-dimethyl-1- (methylcarbamoyl)propyl]-2- [hydroxy-(hydroxycarbamoyl)methyl]- 4- methyl-pentanamide |
|---|---|
| Marimastat CAS number: | 154039-60-8 |
| ATC code: | |
| PubChem: | 119031 |
| DrugBank: | APRD00559 |
| Formula: | C15H29N3O5 |
| Molecular mass: | 331.408 g/mol |
| Marimastat Assay/Purity: | Typically NLT 98% |
